<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03661671</url>
  </required_header>
  <id_info>
    <org_study_id>LCI2018</org_study_id>
    <nct_id>NCT03661671</nct_id>
  </id_info>
  <brief_title>Application of Linked Color Imaging（LCI） in Diagnosis of Early Gastric Cancer(EGC)</brief_title>
  <official_title>Application of Linked Color Imaging（LCI） in Diagnosis of Early Gastric Cancer(EGC): a Multicenter,Prospective, Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanxi Province Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First People's Hospital of Hangzhou</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>307 Hospital of PLA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangsu Province Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Nanchang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhongshan Hospital Xiamen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing University Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guilin Medical University, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Provincial Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xi'an Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the purpose of this study is to evaluate application value of LCI in the diagnosis of early
      gastric cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The detection rate of early gastric cancer is still very low in China. The investigators need
      a new and effective screening method to improve the detection rate. LCI (linked-color
      imaging)is a new model of laser endoscopy which can provide brighter image. LCI can provide
      clear image which can make red part redder and white part whiter, so suspicious lesion could
      be found easier. The study of this randomized controlled trial is to discuss effectiveness of
      LCI in the diagnosis of early gastric cancer and to find a new method to improve the
      detection rate of early gastric cancer in China.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel assignment</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection rate of gastric neoplastic lesion</measure>
    <time_frame>immediately following the procedure</time_frame>
    <description>Include early gastric caner,high grade dysplasia low grade dysplasia and adenoma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Specificity of detecting gastric neoplastic lesion</measure>
    <time_frame>immediately following the procedure</time_frame>
    <description>Include early gastric caner,high grade dysplasia low grade dysplasia and adenoma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of detecting gastric neoplastic lesion</measure>
    <time_frame>immediately following the procedure</time_frame>
    <description>Include early gastric caner,high grade dysplasia low grade dysplasia and adenoma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2400</enrollment>
  <condition>Early Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>LCI+white light</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using white light firstly to observe from cardia to duodenum and then switch LCI model to observe from antrum to cardia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>White light</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Using white light only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>LCI+white light</intervention_name>
    <description>Firstly use white light to observe from cardia to duodenum and then switch LCI model to observe from antrum to cardia</description>
    <arm_group_label>LCI+white light</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. High-risk group of gastric cancer: H. pylori infection; previously suffering from
             chronic atrophic gastritis, intestinal metaplasia, gastric ulcer, gastric polyps,
             residual stomach after surgery, hypertrophic gastritis, malignant anemia and other
             precancerous diseases of gastric cancer;

          2. First degree relatives of patients with gastric cancer;

          3. There are other high risk factors for gastric cancer (high salt, salted diet, smoking,
             heavy drinking, etc.).

          4. Patients with early gastric cancer treated with endoscopic therapy (ESD, EMR).

          5. The informed consent has been signed.

        Exclusion Criteria:

          1. The TNM classification of cancer is consistent with those diagnosed by T2 above.

          2. Patients with abnormal blood coagulation function or taking anticoagulants can not
             biopsy.

          3. There were contraindications for gastroscopy.

          4. A patient without self judgement;

          5. Those who did not sign informed consent.

          6. Previous gastroscopy has found suspicious lesions requiring careful examination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhaoshen Li, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Gastroenterology, Changhai Hospital, Second Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dong Wang, M.D</last_name>
    <phone>8613816758802</phone>
    <email>dongwang0901@sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jie Gao, M.D</last_name>
    <phone>8613761272863</phone>
    <email>jesseegao@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Gastroenterology, Changhai Hospital, Second Military Medical University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Wang, MD</last_name>
      <phone>008613816758802</phone>
      <email>dongwang0901@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Fukuda H, Miura Y, Hayashi Y, Takezawa T, Ino Y, Okada M, Osawa H, Lefor AK, Yamamoto H. Linked color imaging technology facilitates early detection of flat gastric cancers. Clin J Gastroenterol. 2015 Dec;8(6):385-9. doi: 10.1007/s12328-015-0612-9. Epub 2015 Nov 11.</citation>
    <PMID>26560036</PMID>
  </results_reference>
  <results_reference>
    <citation>Okada M, Sakamoto H, Takezawa T, Hayashi Y, Sunada K, Lefor AK, Yamamoto H. Laterally Spreading Tumor of the Rectum Delineated with Linked Color Imaging Technology. Clin Endosc. 2016 Mar;49(2):207-8. doi: 10.5946/ce.2015.077. Epub 2016 Feb 12.</citation>
    <PMID>26867550</PMID>
  </results_reference>
  <results_reference>
    <citation>Sun X, Dong T, Bi Y, Min M, Shen W, Xu Y, Liu Y. Linked color imaging application for improving the endoscopic diagnosis accuracy: a pilot study. Sci Rep. 2016 Sep 19;6:33473. doi: 10.1038/srep33473.</citation>
    <PMID>27641243</PMID>
  </results_reference>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 3, 2018</study_first_submitted>
  <study_first_submitted_qc>September 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2018</study_first_posted>
  <last_update_submitted>September 5, 2018</last_update_submitted>
  <last_update_submitted_qc>September 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Zhaoshen Li</investigator_full_name>
    <investigator_title>Director of Gastroenterology Dept</investigator_title>
  </responsible_party>
  <keyword>Linked-color imaging</keyword>
  <keyword>Detection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

